Glycosylation and lectins-examples of immunesurveillance and immune evasion

Histology and Histopathology

Volumn 19, Issue 2, 2004, Pages 527-533

  Müller, Ingo ^a   Handgretinger, R ^b   Riberdy, J ^b   Kerst, G ^a  

^a Children's Hospital   (Germany)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Carbohydrate receptors; Immune system; Lectin regulation; Tumours

Indexed keywords

CARBOHYDRATE BINDING PROTEIN; CARBOHYDRATE DERIVATIVE; CD22 ANTIGEN; CD33 ANTIGEN; CD48 ANTIGEN; CD83 ANTIGEN; CELL SURFACE PROTEIN; COLLECTIN; GALECTIN; INTERCELLULAR ADHESION MOLECULE 1; LECTIN; MANNAN BINDING LECTIN; PENTRAXIN; PROTEIN P35; PROTEOGLYCAN; SELECTIN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D;

ANTIGEN PRESENTATION; B LYMPHOCYTE ACTIVATION; CANCER CELL; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; HODGKIN DISEASE; HOST RESISTANCE; HUMAN; IMMUNOREGULATION; IMMUNOSURVEILLANCE; MALIGNANT TRANSFORMATION; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVIEW; T LYMPHOCYTE ACTIVATION;

ANIMALS; CARBOHYDRATES; GLYCOCONJUGATES; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; IMMUNE SYSTEM; LECTINS; NEOPLASMS;

EID: 1842506705     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Agrawal B., Krantz M.J., Reddish M.A. and Longenecker B.M. (1998). Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2. Nat. Med. 4, 43-49.
2. Angata T., Kerr S.C., Greaves D.R., Varki N.M., Crocker P.R. and Varki A. (2002). Cloning and characterization of human Siglec-11. A recently evolved signaling that can interact with SHP-1 and SHP-2 and is expressed by tissue macrophages, including brain microglia. J. Biol. Chem. 277, 24466-24474.
3. Blixt O., Collins B.E., van den Nieuwenhof I.M, Crocker P.R. and Paulson J.C. (2003). Sialoside Specificity of the Siglec Family Assessed Using Novel Multivalent Probes: Identification of potent inhibitors of myelin-associated glycoprotein. J. Biol. Chem. 278, 31007-31019.
4. Braud V.M., Allan D.S., O'Callaghan C.A., Soderstrom K., D'Andrea A., Ogg G.S., Lazetic S., Young N.T., Bell J.I., Phillips J.H., Lanier L.L. and McMichael A.J. (1998). HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391, 795-799.
5. Bresalier R.S., Ho S.B., Schoeppner H.L., Kim Y.S., Sleisenger M.H., Brodt P. and Byrd J.C. (1996). Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis. Gastroenterology 110, 1354-1367.
6. Brossart P., Schneider A., Dill P., Schammann T., Grunebach F., Wirths S., Kanz L., Buhring H.J. and Brugger W. (2001). The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes. Cancer Res. 61, 6846-6850.
7. Cajot J.F., Sordat I., Silvestre T. and Sordat B. (1997). Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells. Cancer Res. 57, 2593-2597.
8. Carretero M., Cantoni C., Bellon T., Bottino, C., Biassoni R., Rodriguez A., Perez-Villar J.J., Moretta L., Moretta A. and Lopez-Botet M. (1997). The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur. J. Immunol. 27, 563-567.
9. Chen C.L., Lee W.L., Tsai Y.C., Yuan C.C, Ng H.T. and Wang P.H. (2002). Sialyltransferase family members and cervix squamous cell carcinoma. Eur. J. Gynaecol. Oncol. 23, 514-518.
10. Cramer S.O., Trumpfheller C., Mehlhoop U., More S., Fleischer B. and von Bonin A. (2000). Activation-induced expression of murine CD83 on T cells and identification of a specific CD83 ligand on murine B cells. Int. Immunol. 12, 1347-1351.
11. Crocker P.R. and Varki A. (2001). Siglecs in the immune system. Immunology 103, 137-145.
12. Dahl M.R., Thiel S., Matsushita M., Fujita T., Willis A.C., Christensen T., Vorup-Jensen T. and Jensenius J.C. (2001). MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. Immunity 15, 127-135.
13. Dahms N.M. and Hancock M.K. (2002). P-type lectins. Biochim. Biophys. Acta 1572, 317-340.
14. Daniels M.A., Devine L., Miller J.D., Moser J.M., Lukacher A.E., Altman J.D., Kavathas P., Hogquist K.A. and Jameson S.C. (2001). CD8 binding to MHC class I molecules is influenced by T cell maturation and glycosylation. Immunity 15, 1051-1061.
15. Daniels M.A., Hogquist K.A. and Jameson S.C. (2002). Sweet 'n' sour: The impact of differential glycosylation on T cell responses. Nat. Immunol. 3, 903-910.
16. Demetriou M., Granovsky M., Quaggin S. and Dennis J.W. (2001). Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409, 733-739.
17. Demetriou M., Nabi I.R., Coppolino M., Dedhar S. and Dennis J.W. (1995). Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V. J. Cell Biol. 130, 383-392.
18. Drickamer K. (1988). Two distinct classes of carbohydrate-recognition domains in animal lectins. J. Biol. Chem. 263, 9557-9560.
19. Du Clos T.W. (2003). C-reactive protein as a regulator of autoimmunity and inflammation. Arthritis Rheum. 48, 1475-1477.
20. Dwek R.A., Butters T.D., Platt F.M. and Zitzmann N. (2002). Targeting glycosylation as a therapeutic approach. Nat. Rev. Drug Discov. 1, 65-75.
21. Figdor C.G., van Kooyk Y. and Adema G.J. (2002). C-type lectin receptors on dendritic cells and Langerhans cells, Nat. Rev. Immunol. 2, 77-84.
22. Fujimoto Y., Tu L., Miller A.S., Bock C., Fujimoto M., Doyle C., Steeber D.A. and Tedder T.F. (2002). CD83 expression influences CD4+ T cell development in the thymus. Cell 108, 755-767.
23. Grunewald S., Matthijs G. and Jaeken J. (2002). Congenital disorders of glycosylation: A review. Pediatr. Res. 52, 618-624.
24. Hakim A.A. (1988). A mechanism by which human breast carcinoma cells escape the host immune system. Neoplasma 35, 691-705.
25. Hakomori S. (2002). Glycosylation defining cancer malignancy: new wine in an old bottle. Proc. Natl. Acad. Sci. US.A 99, 10231-10233.
26. Hennet T., Chui D., Paulson J.C. and Marth J.D. (1998). Immune regulation by the ST6Gal sialyltransferase. Proc. Natl. Acad. Sci. USA 95, 4504-4509.
27. Hock B.D., Kato M., McKenzie J.L. and Hart D.N. (2001). A soluble form of CD83 is released from activated dendritic cells and B lymphocytes, and is detectable in normal human sera. Int. Immunol. 13, 959-967.
28. Holmskov U., Thiel S. and Jensenius J.C. (2003). Collectins and ficolins: Humoral lectins of the innate mmune Defense. Annu. Rev. Immunol. 21, 547-578.
29. Hoppe H.J. and Reid K.B. (1994). Collectins - soluble proteins containing collagenous regions and lectin domains - and their roles in innate immunity. Protein Sci. 3, 1143-1158.
30. Ichijo H., Hellman U., Wernstedt C., Gonez L.J., Claesson-Welsh L., Heldin C.H. and Miyazono K. (1993). Molecular cloning and characterization of ficolin, a multimeric protein with fibrinogen- and collagen-like domains. J. Biol. Chem. 268, 14505-14513.
31. 2+)-dependent animal lectins. I. Analysis of mannose binding by site-directed mutagenesis and NMR. J. Biol. Chem. 269, 15505-15511.
32. Jiang M.S., Passaniti A., Penno M.B. and Hart G.W. (1992). Adrenal carcinoma tumor progression and penultimate cell surface oligosaccharides. Cancer Res. 52, 2222-2227.
33. Kakkanaiah V.N., Shen G.Q., Ojo-Amaize E.A. and Peter J.B. (1998). Association of low concentrations of serum mannose-binding protein with recurrent infections in adults. Clin. Diagn. Lab. Immunol. 5, 319-321.
34. Kelm S., Gerlach J., Brossmer R., Danzer C.P. and Nitschke L. (2002). The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound. J. Exp. Med. 195, 1207-1213.
35. Kilpatrick D.C. (2002a). Mannan-binding lectin and its role in innate immunity. Transfus. Med. 12, 335-352.
36. Kilpatrick D.C. (2002b). Mannan-binding lectin: Clinical significance and applications. Biochim. Biophys. Acta 1572, 401-413.
37. Kuhlman M., Joiner K. and Ezekowitz R.A. (1989). The human mannose-binding protein functions as an opsonin. J. Exp. Med. 169, 1733-1745.
38. Lechmann M., Krooshoop D.J., Dudziak D., Kremmer E., Kuhnt C., Figdor C.G., Schuler G. and Steinkasserer A. (2001). The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells. J. Exp. Med. 194, 1813-1821.
39. Lee Y.C. (1992). Biochemistry of carbohydrate-protein interaction. FASEB J. 6, 3193-3200.
40. Lu J., Teh C., Kishore U. and Reid K.B. (2002). Collectins and ficolins: Sugar pattern recognition molecules of the mammalian innate immune system. Biochim. Biophys. Acta 1572, 387-400.
41. Lu J., Wiedemann H., Timpl R. and Reid K.B. (1993). Similarity in structure between C1q and the collectins as judged by electron microscopy. Behring Inst. Mitt. 6-16.
42. Matsushita M., Endo Y. and Fujita T. (2000). Cutting edge: complement-activating complex of ficolin and mannose-binding lectin-associated serine protease. J. Immunol. 164, 2281-2284.
43. Matsushita M., Kuraya M., Hamasaki N., Tsujimura M., Shiraki H. and Fujita T. (2002). Activation of the lectin complement pathway by H-ficolin (Hakata antigen). J. Immunol. 168, 3502-3506.
44. Metzler M., Gertz A., Sarkar M., Schachter H., Schrader J.W. and Marth J.D. (1994). Complex asparagine-linked oligosaccharides are required for morphogenic events during post-implantation development. EMBO J. 13, 2056-2065.
45. Mukherjee P., Ginardi A.R., Madsen C.S., Tinder T.L., Jacobs F., Parker J., Agrawal B., Longenecker B.M. and Gendler S.J. (2001). MUC1-specific CTLs are non-functional within a pancreatic tumor microenvironment. Glycoconj. J. 18, 931-942.
46. Nemoto-Sasaki Y., Mitsuki M., Morimoto-Tomita M., Maeda A., Tsuiji M. and Irimura T. (2001). Correlation between the sialylation of cell surface Thomsen-Friedenreich antigen and the metastatic potential of colon carcinoma cells in a mouse model. Glycoconj. J. 18, 895-906.
47. Ohtani K., Suzuki Y., Eda S., Kawai T., Kase T., Keshi H., Sakai Y., Fukuoh A., Sakamoto T., Itabe H., Suzutani T., Ogasawara M., Yoshida I. and Wakamiya N. (2001). The membrane-type collectin CL-P1 is a scavenger receptor on vascular endothelial cells. J. Biol. Chem. 276, 44222-44228.
48. Ohtani K., Suzuki Y., Eda S., Kawai T., Kase T., Yamazaki H., Shimada T., Keshi H., Sakai Y., Fukuoh A., Sakamoto T. and Wakamiya N. (1999). Molecular cloning of a novel human collectin from liver (CL-L1). J. Biol. Chem. 274, 13681-13689.
49. Pace K.E., Hahn H.P., Pang M., Nguyen J.T. and Baum L.G. (2000). CD7 delivers a pro-apoptotic signal during galectin-1-induced T cell death. J. Immunol. 165, 2331-2334.
50. Petersen S.V., Thiel S. and Jensenius J.C. (2001). The mannan-binding lectin pathway of complement activation: Biology and disease association. Mol. Immunol. 38, 133-149.
51. + T lymphocyte homeostasis by modulating O-glycan biosynthesis. Immunity 12, 273-283.
52. Rabinovich G.A., Rubinstein N. and Fainboim L. (2002). Unlocking the secrets of galectins: A challenge at the frontier of glyco-immunology. J. Leukoc. Biol. 71, 741-752.
53. Roberts A.A., Amano M., Felten C., Galvan M., Sulur G., Pinter-Brown L., Dobbeling U., Burg G., Said J. and Baum L.G. (2003). Galectin-1-mediated apoptosis in mycosis fungoides: The roles of CD7 and cell surface glycosylation. Mod. Pathol. 16, 543-551.
54. Rudd P.M., Elliott T., Cresswell P., Wilson I.A. and Dwek R.A. (2001). Glycosylation and the immune system. Science 291, 2370-2376.
55. Sata T., Roth J., Zuber C., Stamm B. and Heitz P.U. (1991). Expression of alpha 2 6-linked sialic acid residues in neoplastic but not in normal human colonic mucosa. A lectin-gold cytochemical study with Sambucus nigra and Maackia amurensis lectins. Am. J. Pathol. 139, 1435-1448.
56. Scholler N., Hayden-Ledbetter M., Dahlin A., Hellstrom I., Hellstrom K.E. and Ledbetter J.A. (2002). Cutting edge: CD83 regulates the development of cellular immunity. J. Immunol. 168, 2599-2602.
57. Scholler N., Hayden-Ledbetter M., Hellstrom K.E., Hellstrom I. and Ledbetter J.A. (2001). CD83 is a sialic acid-binding Ig-like lectin (Siglec) adhesion receptor that binds monocytes and a subset of activated CD8+ T cells. J. Immunol. 166, 3865-3872.
58. Sinclair N.R. (2000). Immunoreceptor tyrosine-based inhibitory motifs on activating molecules. Crit. Rev. Immunol. 20, 89-102.
59. Sorg U.R., Morse T.M., Patton W.N., Hock B.D., Angus H.B., Robinson B.A., Colls B.M. and Hart D.N. (1997). Hodgkin's cells express CD83, a dendritic cell lineage associated antigen. Pathology 29, 294-299.
60. Stover C.M., Thiel S., Thelen M., Lynch N.J., Vorup-Jensen T., Jensenius J.C. and Schwaeble W.J. (1999). Two constituents of the initiation complex of the mannan-binding lectin activation pathway of complement are encoded by a single structural gene. J. Immunol. 162, 3481-3490.
61. Takahashi M., Endo Y., Fujita T. and Matsushita M. (1999). A truncated form of mannose-binding lectin-associated serine protease (MASP)-2 expressed by alternative polyadenylation is a component of the lectin complement pathway. Int. Immunol. 11, 859-863.
62. Taylor L.S., Paul S.P. and McVicar D.W. (2000). Paired inhibitory and activating receptor signals. Rev. Immunogenet. 2, 204-219.
63. Vitale C., Romagnani C., Falco M., Ponte M., Vitale M., Moretta A., Bacigalupo A., Moretta L. and Mingari M.C. (1999). Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells. Proc. Natl. Acad. Sci. USA 96, 15091-15096.
64. Vlad A.M., Muller S., Cudic M., Paulsen H., Otvos L. Jr., Hanisch F.G. and Finn O.J. (2002). Complex carbohydrates are not removed during processing of glycoproteins by dendritic cells: Processing of tumor antigen MUC1 glycopeptides for presentation to major histocompatibility complex class II-restricted T cells. J. Exp. Med. 196, 1435-1446.
65. Wang F., Goto M., Kim Y.S., Higashi M., Imai K., Sato E. and Yonezawa S. (2001). Altered GalNAc-alpha-2 6-sialylation compartments for mucin-associated sialyl-Tn antigen in colorectal adenoma and adenocarcinoma. J. Histochem. Cytochem. 49, 1581-1592.
66. Yamamoto H., Oviedo A., Sweeley C., Saito T. and Moskal J.P. (2001). Alpha2 6-sialylation of cell-surface N-glycans inhibits glioma formation in vivo. Cancer Res. 61, 6822-6829.
67. Yu F., Finley R.L. Jr., Raz A. and Kim H.R. (2002). Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria. A role for synexin in galectin-3 translocation. J. Biol. Chem. 277, 15819-15827.
68. Zhou L.J., Schwarting R., Smith H.M. and Tedder T.F. (1992). A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J. Immunol. 149, 735-742.
69. Zhou L.J. and Tedder T.F. (1996). CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc. Natl. Acad. Sci. USA 93, 2588-2592.